Bank of New York Mellon’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.73M Buy
+325,296
New +$4.16M ﹤0.01% 2469
2020
Q2
Sell
-22
Closed -$20K 4147
2020
Q1
$20K Hold
22
﹤0.01% 4059
2019
Q4
$50K Hold
22
﹤0.01% 4111
2019
Q3
$43K Hold
22
﹤0.01% 4136
2019
Q2
$49K Sell
22
-1
-4% -$2.42K ﹤0.01% 4124
2019
Q1
$75K Sell
23
-1
-4% -$2.28K ﹤0.01% 4047
2018
Q4
$46K Buy
+24
New +$132K ﹤0.01% 4071
2018
Q1
Sell
-4
Closed -$67K 4406
2017
Q4
$67K Hold
4
﹤0.01% 4159
2017
Q3
$45K Hold
4
﹤0.01% 4119
2017
Q2
$105K Hold
4
﹤0.01% 4018
2017
Q1
$71K Hold
4
﹤0.01% 4092
2016
Q4
$238K Hold
4
﹤0.01% 3845
2016
Q3
$287K Hold
4
﹤0.01% 3778
2016
Q2
$332K Hold
4
﹤0.01% 3709
2016
Q1
$265K Hold
4
﹤0.01% 3685
2015
Q4
$424K Hold
4
﹤0.01% 3601
2015
Q3
$388K Hold
4
﹤0.01% 3690
2015
Q2
$477K Hold
4
﹤0.01% 3653
2015
Q1
$409K Hold
4
﹤0.01% 3690
2014
Q4
$481K Hold
4
﹤0.01% 3638
2014
Q3
$517K Hold
4
﹤0.01% 3611
2014
Q2
$537K Buy
4
+1
+33% +$154K ﹤0.01% 3586
2014
Q1
$588K Buy
+3
New +$594K ﹤0.01% 3524

Other funds holding TENX

Bank of New York Mellon's TENX Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 325,296 shares worth $4.73M. The stake represents ﹤0.01% of the portfolio and ranks #2469 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in TENX as recently as Q1 2020.

Bank of New York Mellon first reported a position in TENX in Q1 2014 and has held it in 23 quarters since. 33 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Bank of New York Mellon held 325,296 shares of Tenax Therapeutics worth $4.73M as of Q2 2026.
  • Tenax Therapeutics was a new Bank of New York Mellon position in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2469 holding.
  • Bank of New York Mellon first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 23 quarters since.
  • 33 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.